Elevated levels may indicate increased tissue susceptibility to copper-mediated damage, particularly when cellular compensatory mechanisms, such as copper buffering or efflux, are impaired [262]
This article is not, nor is it intended to be, a substitute for professional medical advice, diagnosis, or treatment and should never be relied upon for specific medical advice
It is still not FDA-approved and still carries uncertainty, but it exists within a medical and pharmacy framework
KC commented on the manuscript
The four-pathway model therefore targets appetite (GLP-1 and amylin through separate neuronal circuits), fat metabolism (GIP and glucagon), energy expenditure (glucagon primarily), and glucose homeostasis (GLP-1, GIP, and amylin all contribute through different mechanisms)
Shelf life: 3 years